ZA953877B - Novel process - Google Patents
Novel processInfo
- Publication number
- ZA953877B ZA953877B ZA953877A ZA953877A ZA953877B ZA 953877 B ZA953877 B ZA 953877B ZA 953877 A ZA953877 A ZA 953877A ZA 953877 A ZA953877 A ZA 953877A ZA 953877 B ZA953877 B ZA 953877B
- Authority
- ZA
- South Africa
- Prior art keywords
- group
- formula
- image
- compound
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Catalysts (AREA)
- Saccharide Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9409705A GB9409705D0 (en) | 1994-05-14 | 1994-05-14 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA953877B true ZA953877B (en) | 1996-03-07 |
Family
ID=10755162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA953877A ZA953877B (en) | 1994-05-14 | 1995-05-12 | Novel process |
Country Status (22)
Country | Link |
---|---|
US (2) | US5808075A (xx) |
EP (1) | EP0759921B1 (xx) |
JP (1) | JPH10500119A (xx) |
KR (1) | KR100340396B1 (xx) |
CN (3) | CN1048013C (xx) |
AT (1) | ATE244718T1 (xx) |
AU (1) | AU695838B2 (xx) |
BR (1) | BR9507659A (xx) |
CA (1) | CA2190278A1 (xx) |
CZ (1) | CZ334796A3 (xx) |
DE (1) | DE69531242T2 (xx) |
DK (1) | DK0759921T3 (xx) |
ES (1) | ES2202364T3 (xx) |
GB (1) | GB9409705D0 (xx) |
HK (1) | HK1012367A1 (xx) |
HU (1) | HU216629B (xx) |
NO (1) | NO964818L (xx) |
NZ (1) | NZ287038A (xx) |
PL (1) | PL178720B1 (xx) |
PT (1) | PT759921E (xx) |
WO (1) | WO1995031456A1 (xx) |
ZA (1) | ZA953877B (xx) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9421472D0 (en) * | 1994-10-25 | 1994-12-07 | Smithkline Beecham Plc | Novel methods |
AU751607B2 (en) * | 1995-07-29 | 2002-08-22 | Smithkline Beecham Plc | Method of treatment of dementia |
GB9615628D0 (en) * | 1996-07-25 | 1996-09-04 | Smithkline Beecham Plc | Formulation |
EP1009403A4 (en) * | 1997-04-11 | 2002-08-28 | Lilly Co Eli | METHOD FOR TREATING SCHIZOPHRENIA |
WO2006006071A1 (en) * | 2004-07-07 | 2006-01-19 | Pfizer Products Inc. | Resolution of an aryl-fused azapolycyclic compound |
GB0428170D0 (en) * | 2004-12-23 | 2005-01-26 | Biopartners Ltd | Mono and Combination Therapy |
AU2006282896A1 (en) * | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
EP1940389A2 (en) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
US7678808B2 (en) | 2006-05-09 | 2010-03-16 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
EP2382975A3 (en) | 2006-05-09 | 2012-02-29 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
JP2010502722A (ja) | 2006-09-08 | 2010-01-28 | ブレインセルス,インコーポレイティド | 4−アシルアミノピリジン誘導体を含む組み合わせ |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3904632A (en) * | 1972-05-08 | 1975-09-09 | Hoffmann La Roche | (')-di-o-isopropylidene-2-keto-l-gulonates |
FR2183565B1 (xx) * | 1972-05-10 | 1975-12-26 | Cerm Cent Europ Rech Mauvernay | |
CA1014958A (en) * | 1973-10-05 | 1977-08-02 | Jacques Moleyre | .alpha.-QUINUCLIDYLMETHYL PHENYL KETONES |
WO1984000957A1 (en) * | 1982-09-07 | 1984-03-15 | Yoshitomi Pharmaceutical | 4-amino-tetrahydro-2-naphthoic acid derivatives |
DE69034146T2 (de) * | 1989-04-13 | 2005-07-14 | Beecham Group P.L.C., Brentford | Chemische Verbindungen |
DK198590D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
US5418240A (en) * | 1990-08-21 | 1995-05-23 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
MX9300875A (es) * | 1992-02-20 | 1993-08-31 | Smithkline Beecham Plc | Procedimiento para la preparacion de compuestos azabiciclicos. |
-
1994
- 1994-05-14 GB GB9409705A patent/GB9409705D0/en active Pending
-
1995
- 1995-05-09 HU HU9603145A patent/HU216629B/hu not_active IP Right Cessation
- 1995-05-09 ES ES95920011T patent/ES2202364T3/es not_active Expired - Lifetime
- 1995-05-09 BR BR9507659A patent/BR9507659A/pt not_active Application Discontinuation
- 1995-05-09 US US08/737,427 patent/US5808075A/en not_active Expired - Fee Related
- 1995-05-09 DE DE69531242T patent/DE69531242T2/de not_active Expired - Fee Related
- 1995-05-09 NZ NZ287038A patent/NZ287038A/en unknown
- 1995-05-09 AU AU25628/95A patent/AU695838B2/en not_active Ceased
- 1995-05-09 PL PL95317210A patent/PL178720B1/pl not_active IP Right Cessation
- 1995-05-09 CA CA002190278A patent/CA2190278A1/en not_active Abandoned
- 1995-05-09 AT AT95920011T patent/ATE244718T1/de not_active IP Right Cessation
- 1995-05-09 EP EP95920011A patent/EP0759921B1/en not_active Expired - Lifetime
- 1995-05-09 CZ CZ963347A patent/CZ334796A3/cs unknown
- 1995-05-09 PT PT95920011T patent/PT759921E/pt unknown
- 1995-05-09 CN CN95193952A patent/CN1048013C/zh not_active Expired - Fee Related
- 1995-05-09 WO PCT/EP1995/001757 patent/WO1995031456A1/en not_active Application Discontinuation
- 1995-05-09 KR KR1019960706442A patent/KR100340396B1/ko not_active IP Right Cessation
- 1995-05-09 JP JP7529334A patent/JPH10500119A/ja not_active Ceased
- 1995-05-09 DK DK95920011T patent/DK0759921T3/da active
- 1995-05-12 US US08/439,616 patent/US5773619A/en not_active Expired - Fee Related
- 1995-05-12 ZA ZA953877A patent/ZA953877B/xx unknown
-
1996
- 1996-11-13 NO NO964818A patent/NO964818L/no unknown
-
1998
- 1998-12-15 HK HK98113521A patent/HK1012367A1/xx not_active IP Right Cessation
-
1999
- 1999-03-13 CN CN99103926A patent/CN1104431C/zh not_active Expired - Fee Related
- 1999-03-13 CN CN99103925A patent/CN1108302C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
HK1012367A1 (en) | 1999-07-30 |
CN1270170A (zh) | 2000-10-18 |
EP0759921B1 (en) | 2003-07-09 |
ES2202364T3 (es) | 2004-04-01 |
CN1048013C (zh) | 2000-01-05 |
US5773619A (en) | 1998-06-30 |
HU216629B (hu) | 1999-07-28 |
AU2562895A (en) | 1995-12-05 |
BR9507659A (pt) | 1997-10-07 |
AU695838B2 (en) | 1998-08-20 |
PL178720B1 (pl) | 2000-06-30 |
CZ334796A3 (en) | 1997-07-16 |
KR100340396B1 (ko) | 2002-10-25 |
DE69531242D1 (de) | 2003-08-14 |
DE69531242T2 (de) | 2004-05-27 |
CN1151743A (zh) | 1997-06-11 |
CN1104431C (zh) | 2003-04-02 |
NO964818D0 (no) | 1996-11-13 |
PT759921E (pt) | 2003-11-28 |
EP0759921A1 (en) | 1997-03-05 |
NO964818L (no) | 1997-01-13 |
HU9603145D0 (en) | 1997-01-28 |
GB9409705D0 (en) | 1994-07-06 |
PL317210A1 (en) | 1997-03-17 |
ATE244718T1 (de) | 2003-07-15 |
NZ287038A (en) | 1997-11-24 |
CN1108302C (zh) | 2003-05-14 |
HUT75309A (en) | 1997-05-28 |
KR970703342A (ko) | 1997-07-03 |
US5808075A (en) | 1998-09-15 |
WO1995031456A1 (en) | 1995-11-23 |
CN1232825A (zh) | 1999-10-27 |
JPH10500119A (ja) | 1998-01-06 |
CA2190278A1 (en) | 1995-11-23 |
DK0759921T3 (da) | 2003-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA953877B (en) | Novel process | |
US4302465B1 (xx) | ||
ZA944884B (en) | Derivatives of valproic acid amides and 2-valproenoic acid amides method of making and use thereof as anticonvulsant agent | |
HU9702482D0 (en) | New intermediates for producing gaba and l-glutaminic acid analogues | |
GR69233B (xx) | ||
ES8503667A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina. | |
DE3372362D1 (en) | Polyprenylcarboxylic acid amides and process for preparing the same | |
CA2131019A1 (en) | Nitrosation process | |
IE781926L (en) | Peptides analgesics | |
ZA816259B (en) | 2-(1,4-benzodioxan-2-ylalkyl)imidazoles useful as antidepressants | |
IE830278L (en) | Corynanthein derivatives, anti-hypertensives | |
HUT50845A (en) | Process for producing 14,17beta-ethano-14beta-estratrienes and pharmaceutical compositions comprising same | |
ES8401761A1 (es) | Un procedimiento para la preparacion de derivados de 1-(3,4,5-trimetoxicinamoil)-4-aminocarboniletil-piperazina sustituidos. | |
CA2208520A1 (en) | Diclavulanate salt with a diamino ether and process of preparation | |
MX9605632A (es) | Procedimiento para la preparacion de derivados azabiciclicos. | |
DE3564426D1 (en) | Polyprenyl compound, process of producing it and pharmaceutical use | |
ES479712A1 (es) | Procedimiento para la preparacion de n-bencilaminoacidos quecontienen azufre. | |
ATE20742T1 (de) | Verfahren zur herstellung von pyrazin-derivaten. | |
ES2007784A6 (es) | Procedimiento para la preparacion de derivados de 1-alquil-ergolinil-tiourea> | |
IL113757A (en) | Preparation of clavulanic acid | |
ES481416A1 (es) | Un procedimiento para la preparacion de un derivado monoami-da de acido tereftalico. | |
ES8704175A1 (es) | Un procedimiento para la preparacion de derivados de benzopirano (2,3-d) triazol. | |
ATE49967T1 (de) | Verfahren zur herstellung von n-methyl-derivaten von methylester von dihydrolyserginesaeure oder von methylester von methoxylumilyserginesaeure. |